Risk of preeclampsia is two-fold higher in women with systemic lupus erythematosus (SLE), whether they use disease-modifying antirheumatic drugs (DMARDs), corticosteroids, or nonsteroidal inflammatory drugs (NSAIDs), according to a retrospective study.
